Aprea Therapeutics (APRE) Short Interest Ratio & Short Volume $3.08 -0.26 (-7.78%) (As of 12/18/2024 05:44 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aprea Therapeutics Short Interest DataAprea Therapeutics (APRE) has a short interest of 11,000 shares, representing 0.23% of the float (the number of shares available for trading by the public). This marks a 15.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 20,427 shares to cover all short positions.Current Short Interest11,000 sharesPrevious Short Interest9,500 sharesChange Vs. Previous Month+15.79%Dollar Volume Sold Short$31,900.00Short Interest Ratio0.4 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares5,435,000 sharesFloat Size4,760,000 sharesShort Percent of Float0.23%Today's Trading Volume17,544 sharesAverage Trading Volume20,427 sharesToday's Volume Vs. Average86% Short Selling Aprea Therapeutics? Sign up to receive the latest short interest report for Aprea Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPRE Short Interest Over TimeAPRE Days to Cover Over TimeAPRE Percentage of Float Shorted Over Time Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Aprea Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202411,000 shares $31,900.00 +15.8%0.2%0.4 $2.90 11/15/20249,500 shares $30,590.00 -67.2%0.2%0.4 $3.22 10/31/202429,000 shares $113,390.00 +90.8%0.6%1.3 $3.91 10/15/202415,200 shares $46,816.00 +15.2%0.3%0.7 $3.08 9/30/202413,200 shares $36,300.00 +26.9%0.3%1 $2.75 9/15/202410,400 shares $32,761.04 -5.5%0.2%1.3 $3.15 Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202411,000 shares $37,716.80 -34.1%0.2%1.2 $3.43 8/15/202416,700 shares $56,947.00 +36.9%0.4%1.7 $3.41 7/31/202412,200 shares $45,140.00 -41.4%0.3%1.2 $3.70 7/15/202420,800 shares $81,536.00 -6.3%0.4%2.3 $3.92 6/30/202422,200 shares $90,354.00 +13.3%0.5%2.4 $4.07 6/15/202419,600 shares $86,349.76 -7.6%0.4%1.9 $4.41 5/31/202421,200 shares $101,124.00 -34.6%0.4%0.7 $4.77 5/15/202432,400 shares $187,920.00 -64.3%0.7%1.1 $5.80 4/30/202490,700 shares $462,570.00 -5.7%1.9%3 $5.10 4/15/202496,200 shares $570,466.00 -9.1%2.0%2.9 $5.93 3/31/2024105,800 shares $707,802.00 -9.7%2.4%3.1 $6.69 3/15/2024117,100 shares $724,849.00 +66.8%3.8%3.3 $6.19 2/29/202470,200 shares $593,892.00 -11.6%2.2%2.1 $8.46 2/15/202479,400 shares $450,992.00 -20.5%2.5%5.6 $5.68 1/31/202499,900 shares $516,483.00 -17.0%3.2%7.6 $5.17 1/15/2024120,300 shares $671,274.00 +5.7%3.8%10.7 $5.58 12/31/2023113,800 shares $534,860.00 -1.6%3.6%10.4 $4.70 12/15/2023115,700 shares $444,288.00 -1.6%3.7%11.6 $3.84 11/30/2023117,600 shares $428,064.00 -2.4%3.8%11.4 $3.64 11/15/2023120,500 shares $477,180.00 +4.1%3.9%11.4 $3.96 10/31/2023115,800 shares $394,878.00 -3.3%3.7%9.4 $3.41 10/15/2023119,700 shares $629,622.00 +0.9%3.8%7.5 $5.26 9/30/2023118,600 shares $494,146.90 -5.7%3.8%2.6 $4.17 9/15/2023125,800 shares $503,200.00 -1.3%4.0%2.8 $4.00 8/31/2023127,500 shares $470,475.00 -5.0%4.1%2.8 $3.69 8/15/2023134,200 shares $483,120.00 -9.1%4.3%2.8 $3.60 7/31/2023147,700 shares $457,870.00 +427.5%4.7%3.2 $3.10 7/15/202328,000 shares $87,640.00 +9.4%0.9%0.6 $3.13 6/30/202325,600 shares $80,640.00 +161.2%0.8%2 $3.15 6/15/20239,800 shares $33,418.00 -58.5%0.3%0.7 $3.41 5/31/202323,600 shares $90,860.00 -4.8%0.8%1.8 $3.85 5/15/202324,800 shares $90,768.00 -30.3%0.8%1.7 $3.66 4/30/202335,600 shares $141,154.00 +20.3%1.1%2.3 $3.97 4/15/202329,600 shares $121,360.00 +46.5%0.9%2 $4.10Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/202320,200 shares $89,688.00 -56.2%0.6%1.2 $4.44 3/15/202346,100 shares $240,642.00 +31.0%1.4%2.9 $5.22 2/28/202335,200 shares $180,576.00 -3.3%1.0%2.5 $5.13 2/15/202336,400 shares $283,920.00 -94.4%1.9%2.8 $7.80 1/31/2023646,700 shares $324,320.05 -24.3%N/A3 $0.50 1/15/2023854,200 shares $416,507.92 +6.2%N/A4.1 $0.49 12/30/2022804,300 shares $266,223.30 +9.9%N/A5.7 $0.33 12/15/2022731,700 shares $278,046.00 -0.8%N/A5.7 $0.38 11/30/2022737,800 shares $306,187.00 -9.3%N/A5 $0.42 11/15/2022813,300 shares $333,453.00 -8.2%N/A5.4 $0.41 10/31/2022885,700 shares $593,330.43 -9.0%4.5%7.2 $0.67 10/15/2022973,700 shares $740,012.00 +18.5%5.0%7 $0.76 9/30/2022821,800 shares $534,170.00 -6.1%4.2%3.1 $0.65 9/15/2022875,500 shares $773,154.05 +24.7%4.5%1.2 $0.88 8/31/2022701,900 shares $557,378.79 +3.1%3.6%1 $0.79 8/15/2022681,100 shares $626,612.00 -14.9%3.5%0.9 $0.92 7/31/2022800,200 shares $768,192.00 -61.5%4.1%0.9 $0.96 7/15/20222,080,000 shares $2.33 million +154.3%11.8%2.3 $1.12 6/30/2022817,900 shares $613,425.00 -14.7%4.6%1 $0.75 6/15/2022958,400 shares $797,388.80 -18.1%5.8%2.5 $0.83 5/31/20221,170,000 shares $979,875.00 +22.0%7.1%2.6 $0.84 5/15/2022959,100 shares $1.14 million +2.1%5.7%2.3 $1.19 4/30/2022939,700 shares $1.37 million -9.6%5.5%2.9 $1.46 4/15/20221,040,000 shares $1.71 million +7.3%6.1%2.9 $1.64 3/31/2022969,500 shares $1.80 million +11.0%5.8%2.6 $1.86 3/15/2022873,700 shares $1.52 million -5.8%5.2%2 $1.74 2/28/2022927,800 shares $1.61 million -5.6%5.6%1.5 $1.74 2/15/2022983,000 shares $1.84 million +30.8%5.9%1.5 $1.87 1/31/2022751,400 shares $1.57 million +35.6%4.8%1 $2.09 1/15/2022554,300 shares $1.46 million -17.6%3.6%0.7 $2.64 12/31/2021672,500 shares $1.93 million -36.6%4.3%0.7 $2.87 12/15/20211,060,000 shares $3.65 million +43.9%6.8%0.9 $3.44 11/30/2021736,600 shares $2.98 million +12.9%4.8%0.5 $4.04 11/15/2021652,200 shares $3.14 million -27.2%4.2%0.4 $4.82 10/29/2021895,400 shares $4.43 million +7.4%5.9%0.6 $4.95 10/15/2021833,500 shares $4.28 million +3.5%5.5%0.6 $5.14 9/30/2021805,300 shares $4.12 million +171.0%5.3%0.4 $5.11 9/15/2021297,200 shares $1.38 million -57.3%2.0%0.2 $4.64 8/31/2021695,800 shares $3.21 million -24.2%4.6%0.2 $4.62 8/13/2021917,400 shares $3.35 million -27.2%6.0%0.3 $3.65 7/30/20211,260,000 shares $5.33 million +15.6%8.5%0.4 $4.23 7/15/20211,090,000 shares $5.55 million -42.3%7.4%0.3 $5.09 6/30/20211,890,000 shares $9.22 million +29.5%12.8%0.6 $4.88 6/15/20211,460,000 shares $7.08 million +2.8%9.9%0.5 $4.85 5/28/20211,420,000 shares $5.99 million -15.0%9.6%2 $4.22 5/14/20211,670,000 shares $6.76 million +17.6%11.3%2.2 $4.05 4/30/20211,420,000 shares $6.75 million -15.0%9.6%1.4 $4.75 4/15/20211,670,000 shares $7.41 million +11.3%11.7%1.3 $4.44 3/31/20211,500,000 shares $7.19 million +14.5%10.5%1 $4.79 3/15/20211,310,000 shares $7.81 million -8.4%9.2%0.7 $5.96Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/26/20211,430,000 shares $8.58 million -24.3%9.9%0.9 $6.00 2/12/20211,890,000 shares $13.89 million -2.6%12.7%1.2 $7.35 1/29/20211,940,000 shares $10.50 million +84.8%14.6%1.4 $5.41 1/15/20211,050,000 shares $5.47 million -40.3%7.9%1 $5.21 12/31/20201,760,000 shares $8.92 million +64.5%13.2%2.2 $5.07 12/15/20201,070,000 shares $30.76 million +11.6%8.0%5.9 $28.75 11/30/2020958,800 shares $25.36 million -10.4%7.2%5.7 $26.45 11/15/20201,070,000 shares $22.89 million -3.6%8.0%7.4 $21.39 10/30/20201,110,000 shares $25.09 million -0.9%8.7%9.3 $22.60 10/15/20201,120,000 shares $28.84 million -3.5%8.7%11.6 $25.75 9/30/20201,160,000 shares $27.91 million -4.1%9.3%13.4 $24.06 9/15/20201,210,000 shares $34.51 million -11.0%9.7%13.5 $28.52 8/31/20201,360,000 shares $36.86 million +0.7%10.9%9.8 $27.10 8/14/20201,350,000 shares $37.29 million -3.6%10.9%8.8 $27.62 7/31/20201,400,000 shares $38.40 million +20.7%11.4%8.7 $27.43 7/15/20201,160,000 shares $33.30 million +11.5%9.3%7.3 $28.71 6/30/20201,040,000 shares $37.92 million +36.3%8.5%7 $36.46 6/15/2020763,200 shares $23.40 million +2.6%6.2%5.6 $30.66 5/29/2020743,900 shares $19.98 million -12.5%6.2%8.4 $26.86 5/15/2020850,300 shares $29.20 million -3.0%7.1%10.3 $34.34 4/30/2020876,800 shares $29.11 million +3.5%8.4%12.2 $33.20 4/15/2020847,300 shares $28.81 million +34.0%8.1%11.3 $34.00 3/31/2020632,500 shares $21.35 million +44.6%6.2%7.7 $33.75 3/13/2020437,500 shares $14.70 million +4.2%4.3%4.8 $33.61 2/28/2020419,900 shares $14.89 million +45.8%4.1%3.7 $35.47 2/14/2020288,000 shares $9.92 million +1.6%2.8%2.5 $34.43 1/31/2020283,500 shares $9.82 million +61.4%2.8%2.5 $34.65 1/15/2020175,700 shares $6.08 million -21.3%1.7%1.5 $34.62 12/31/2019223,200 shares $8.61 million No Change2.2%1.9 $38.58 APRE Short Interest - Frequently Asked Questions What is Aprea Therapeutics' current short interest? Short interest is the volume of Aprea Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 11,000 shares of APRE short. 0.23% of Aprea Therapeutics' shares are currently sold short. Learn More on Aprea Therapeutics' current short interest. What is a good short interest percentage for Aprea Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.23% of Aprea Therapeutics' floating shares are currently sold short. Is Aprea Therapeutics' short interest increasing or decreasing? Aprea Therapeutics saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 11,000 shares, an increase of 15.8% from the previous total of 9,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aprea Therapeutics' float size? Aprea Therapeutics currently has issued a total of 5,435,000 shares. Some of Aprea Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aprea Therapeutics currently has a public float of 4,760,000 shares. How does Aprea Therapeutics' short interest compare to its competitors? 0.23% of Aprea Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aprea Therapeutics: Repare Therapeutics Inc. (2.00%), BioAtla, Inc. (8.23%), Cue Biopharma, Inc. (1.58%), SELLAS Life Sciences Group, Inc. (12.86%), InterCure Ltd. (0.14%), DBV Technologies S.A. (1.82%), Oncolytics Biotech Inc. (2.97%), BeyondSpring Inc. (8.38%), Connect Biopharma Holdings Limited (0.11%), Atara Biotherapeutics, Inc. (12.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Aprea Therapeutics stock? Short selling APRE is an investing strategy that aims to generate trading profit from Aprea Therapeutics as its price is falling. APRE shares are trading down $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aprea Therapeutics? A short squeeze for Aprea Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APRE, which in turn drives the price of the stock up even further. How often is Aprea Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APRE, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Repare Therapeutics Short Interest Data BioAtla Short Interest Data Cue Biopharma Short Interest Data SELLAS Life Sciences Group Short Interest Data InterCure Short Interest Data DBV Technologies Short Interest Data Oncolytics Biotech Short Interest Data BeyondSpring Short Interest Data Connect Biopharma Short Interest Data Atara Biotherapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APRE) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APRE Stock Alerts